Live tape
Top 8, mentions 7d7,974NKE2,140 mentions▲ +0.03GOOGL1,372 mentions▲ +0.04NVDA1,095 mentions▲ +0.10SPCX839 mentions▲ +0.09QQQ783 mentions▲ +0.09SPY587 mentions▲ +0.06MSFT581 mentions▲ +0.05TSLA577 mentions▲ +0.06

Equity · Healthcare

ATR

NYSE

AptarGroup, Inc.

$120 −0.42% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 6, 2026
Price · Chart
63 sessions
$140 $110 9 Jul 6 Oct

The line runs $125 on 9 July through $120 on 6 October, on a scale from $110 to $140. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 63 sessions, 9 Jul – 6 Oct 2026
Market cap $7.6B
P/E (TTM) 21.7
52-week range $111.96 – $146
Avg volume 23.9K

as of Oct 6, 2026

ATR insider trades

SEC Form 4 · last 90 days · newest reported trade 2 Sep 2026
Open-market buys 0
Open-market sells 5
Net sold $3.61M
Non-trade filings 11
Date Insider Type Shares Value
02 Sep 2026 Vinczeller Shiela Chief Human Resources Officer Sell 765 $100K
27 Aug 2026 Touya Gael Segment Pres., CEO Designate Sell 3,740 $500K
04 Aug 2026 Prieur Marc Segment President Sell 3,500 $477K
03 Aug 2026 Tlili Hedi Segment President Sell 8,854 $1.20M
03 Aug 2026 Tanda Stephan B. President and CEO Sell 9,838 $1.34M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
01 Sep 2026 Touya Gael President and CEO Award 2,637
03 Aug 2026 Tanda Stephan B. President and CEO Option exercise 9,838 $736K
16 Jul 2026 Trerotola Matthew L. Director Award 151
16 Jul 2026 Xing Julie Director Award 151
16 Jul 2026 Glickman Sarah JS Director Award 151
16 Jul 2026 Owens B Craig Director Award 151
16 Jul 2026 Wunderlich Ralf K. Director Award 151
16 Jul 2026 Matthews Candace S. Director Award 226
16 Jul 2026 Marey-Semper Isabel Director Award 151
16 Jul 2026 Kampouri Monnas Giovanna Director Award 151
16 Jul 2026 FOTIADES GEORGE L Director Award 151

ATR reported financials

SEC EDGAR XBRL SEC EDGAR

ATR reported revenue of $3.8B for the fiscal year ended 31 Dec 2025. Net income over the same period was $392.8M.

Figure Reported Period
Revenue $3.8B 31 Dec 2025 fiscal year
Net income $392.8M 31 Dec 2025 fiscal year
Diluted EPS $5.89 31 Dec 2025 fiscal year
Total assets $5.1B 30 Jun 2026 at period end
Total equity $2.6B 30 Jun 2026 at period end

ATR earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $1.36 $1.03B
31 Mar 2026 Q1 2026 $1.12 $983M
31 Dec 2025 FY 2025 $5.89 $3.78B
30 Sep 2025 Q3 2025 $1.92 $961M
30 Jun 2025 Q2 2025 $1.67 $966M
31 Mar 2025 Q1 2025 $1.17 $887M
31 Dec 2024 FY 2024 $5.53 $3.58B
30 Sep 2024 Q3 2024 $1.48 $909M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

ATR institutional holders

SEC Form 13F SEC EDGAR

10 of the 45 institutional funds we track reported a ATR position for the quarter ended 30 Jun 2026 — a combined $242.8M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
AQR Capital Management Trimmed −44.7% shares 680,207 $84.7M
D. E. Shaw & Co. Held (±25%) −18.6% shares 392,399 $49.1M
Citadel Advisors Added +757.8% shares 240,856 $30.2M
Renaissance Technologies Held (±25%) −1.4% shares 170,400 $21.3M
Millennium Management Trimmed −40.4% shares 155,567 $19.5M
Balyasny Asset Management Trimmed −43.0% shares 154,806 $19.4M
Two Sigma Investments Added +45.6% shares 90,996 $11.4M
Man Group Trimmed −60.6% shares 26,164 $3.3M
Fisher Asset Management Held (±25%) −11.6% shares 20,117 $2.5M
Marshall Wace Added +223.0% shares 11,174 $1.4M

ATR fails-to-deliver

SEC CNS data SEC

On 08 Sep 2026, 32 shares of ATR failed to deliver (about $4K).

Settlement date Shares failed Notional % of shares out
08 Sep 2026 32 $4K <0.001%
02 Sep 2026 53 $7K <0.001%
31 Aug 2026 25 $3K <0.001%
26 Aug 2026 6 $808 <0.001%

Congressional trades in ATR

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in ATR is a purchase by Lisa C. McClain (house, MI), dated 24 Jun 2025.

Date Member Type Amount
24 Jun 2025 filed 13 Aug 2025 Lisa C. McClain house · Republican–MI Purchase $1K–$15K
05 Mar 2019 filed 06 Apr 2019 Bradley Scott Schneider house · Democrat–IL Sale $250K–$500K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings